Literature DB >> 19572995

Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation.

Leila Sahlstedt1, Leni von Bonsdorff, Freja Ebeling, Jaakko Parkkinen, Eeva Juvonen, Tapani Ruutu.   

Abstract

Free iron induced hydroxyl radical formation is one possible mechanism for tissue injury during cytotoxic therapy. We studied the appearance of free, non-transferrin-bound iron (NTBI) at baseline and during the 20-d period after the onset of cytotoxic chemotherapy in patients with haematological malignancy undergoing intensive chemotherapy or conditioning for autologous stem cell transplantation (aSCT). NTBI was detected on average for 15.6 d in patients treated with chemotherapy only, and for 6.1 d in patients undergoing aSCT. The recovery of the bone marrow function coincided with the disappearance of NTBI. The type of the conditioning regimen was also associated with the appearance of NTBI. The timing of the presence of NTBI accords with the presence of the most important non-infectious complication of intensive chemotherapy and autologous transplantation, mucosal injury, and free iron is likely to contribute to this and probably other complications of the intensive treatments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19572995     DOI: 10.1111/j.1600-0609.2009.01310.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  11 in total

Review 1.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

2.  Does iron overload really matter in stem cell transplantation?

Authors:  Philippe Armand; Marie-Michele Sainvil; Haesook T Kim; Joanna Rhodes; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Ellis J Neufeld; Raymond Y Kwong; Robert J Soiffer; Joseph H Antin
Journal:  Am J Hematol       Date:  2012-04-04       Impact factor: 10.047

3.  Iron overload in transfusion-dependent patients.

Authors:  Thomas D Coates
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.

Authors:  Philippe Armand; Haesook T Kim; Joanna Rhodes; Marie-Michele Sainvil; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Doreen Hearsey; Ellis J Neufeld; Mark D Fleming; Hanno Steen; Damon Anderson; Raymond Y Kwong; Robert J Soiffer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-18       Impact factor: 5.742

5.  Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.

Authors:  Tatsunori Goto; Katsuya Ikuta; Yoshihiro Inamoto; Sonoko Kamoshita; Emi Yokohata; Daisuke Koyama; Koichi Onodera; Aika Seto; Keisuke Watanabe; Nobuhiko Imahashi; Shokichi Tsukamoto; Yukiyasu Ozawa; Katsunori Sasaki; Masafumi Ito; Yutaka Kohgo; Koichi Miyamura
Journal:  Int J Hematol       Date:  2012-12-23       Impact factor: 2.490

6.  Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.

Authors:  John C Wood; Alan R Cohen; Sara L Pressel; Banu Aygun; Hamayun Imran; Lori Luchtman-Jones; Alexis A Thompson; Beng Fuh; William H Schultz; Barry R Davis; Russell E Ware
Journal:  Br J Haematol       Date:  2015-11-02       Impact factor: 6.998

7.  Hepcidin messenger RNA expression in human lymphocytes.

Authors:  Jorge P Pinto; Vera Dias; Heinz Zoller; Graça Porto; Helena Carmo; Félix Carvalho; Maria de Sousa
Journal:  Immunology       Date:  2010-01-19       Impact factor: 7.397

Review 8.  Iron overload in the HCT patient: a review.

Authors:  Pavan Tenneti; Aleksander Chojecki; Mary Ann Knovich
Journal:  Bone Marrow Transplant       Date:  2021-03-29       Impact factor: 5.174

9.  The Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14.

Authors:  Ningning Zhao; An-Sheng Zhang; Aaron M Wortham; Shall Jue; Mitchell D Knutson; Caroline A Enns
Journal:  Nutrients       Date:  2017-12-08       Impact factor: 5.717

10.  Treating thalassemia major-related iron overload: the role of deferiprone.

Authors:  Vasilios Berdoukas; Kallistheni Farmaki; Susan Carson; John Wood; Thomas Coates
Journal:  J Blood Med       Date:  2012-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.